These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 30032935)
21. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Lee S; Lee YB; Choe SJ; Lee WS Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635 [TBL] [Abstract][Full Text] [Related]
23. A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia: finasteride has comparable urinary symptom efficacy and prostate volume reduction, but less sexual side effects and breast complications than dutasteride. Kaplan SA; Chung DE; Lee RK; Scofield S; Te AE Int J Clin Pract; 2012 Nov; 66(11):1052-5. PubMed ID: 23067029 [TBL] [Abstract][Full Text] [Related]
24. Finasteride in benign prostatic hyperplasia. Wysowski DK; Farinas E N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649 [No Abstract] [Full Text] [Related]
27. An evaluation of the federal adverse events reporting system data on adverse effects of 5-alpha reductase inhibitors. Harrell MB; Ho K; Te AE; Kaplan SA; Chughtai B World J Urol; 2021 Apr; 39(4):1233-1239. PubMed ID: 32596745 [TBL] [Abstract][Full Text] [Related]
28. The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model. Da Silva MHA; Costa WS; B Sampaio FJ; De Souza DB Asian J Androl; 2018; 20(5):505-510. PubMed ID: 29893293 [TBL] [Abstract][Full Text] [Related]
29. [How effective is finasteride?]. Krome S Dtsch Med Wochenschr; 2011 Feb; 136(8):354. PubMed ID: 21348003 [No Abstract] [Full Text] [Related]
30. Post-finasteride syndrome: a surmountable challenge for clinicians. Traish AM Fertil Steril; 2020 Jan; 113(1):21-50. PubMed ID: 32033719 [TBL] [Abstract][Full Text] [Related]
31. Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride. Kuiper JG; Bezemer ID; Driessen MT; Vasylyev A; Roehrborn CG; Penning-van Beest FJ; Herings RM BMC Urol; 2016 Aug; 16(1):53. PubMed ID: 27580700 [TBL] [Abstract][Full Text] [Related]
35. Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? Pirozzi L; Sountoulides P; Castellan P; Presicce F; Lombardo R; Romero M; De Nunzio C; Tubaro A; Schips L; Cindolo L Curr Drug Targets; 2015; 16(11):1165-71. PubMed ID: 25981606 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature. Busetto GM; Del Giudice F; D'Agostino D; Romagnoli D; Minervini A; Rocco B; Antonelli A; Celia A; Schiavina R; Cindolo L; Chung BI; Kim JH; Maggi M; Sciarra A; De Berardinis E; Porreca A Arch Ital Urol Androl; 2020 Jan; 91(4):205-210. PubMed ID: 31937082 [TBL] [Abstract][Full Text] [Related]
37. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation. Gur S; Kadowitz PJ; Hellstrom WJ Expert Opin Drug Saf; 2013 Jan; 12(1):81-90. PubMed ID: 23173718 [TBL] [Abstract][Full Text] [Related]
38. [Combination therapy for benign prostatic hyperplasia in the light of clinical guidelines]. Vinarov AZ; Spivak LG; Mironov AV Urologiia; 2017 Sep; (4):120-128. PubMed ID: 28952704 [TBL] [Abstract][Full Text] [Related]
39. Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Duan Y; Grady JJ; Albertsen PC; Helen Wu Z Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):340-348. PubMed ID: 29316005 [TBL] [Abstract][Full Text] [Related]
40. Re: inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction. Kaplan SA J Urol; 2014 Mar; 191(3):752. PubMed ID: 24522062 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]